Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices.
Policies or Program
Economic Growth Initiatives as it relates to clinical trials investment, life sciences industry.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry
Federal healthcare strategy with respect to COVID-19 as well as Public Health Strategies.
Federal healthcare strategy with respect to patient safety, medication errors, healthcare worker safety, infection and disease prevention, and laboratory diagnostic testing.
Federal science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes.
Federal science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry.
Innovation Agenda - as it relates to the Life Science Industry and the Federal Initiative lead by Innovation, Science, Economic Development
Medical Devices Bureau, Biologics and Genetic Therapies Directorate as it relates to policies affecting the review and approval of submissions.